# MARKET_RESEARCH_LOG_2026-08-26

> Production GenGe V3.1.1 hourly scan handoff. Repository `main` remains the source of truth. This log records completed production artifacts and is not an automatic trading instruction.

## GenGe V3.1.1 production promotion and current-date dry-run

- Production decision: `PROMOTE_CONFIDENCE_GATE_ONLY`.
- Current version: `GEN_GE_V3_1_1_PRODUCTION`.
- Round 8 discovery passed all frozen thresholds. Round 9 confirmed PIT, confidence, Sharpe, drawdown, CAGR and cash requirements; full V3.2 was rejected because its 12-month SELL opportunity cost exceeded the frozen limit.
- The original immediate V3.1 SELL ladder remains active. LOW/INVALID valuation confidence now forces HOLD_REVIEW; Hard Gate FAIL still forces EXIT.
- The original current-date dry-run and earlier intraday scans are retained in git history. No Round 10 or V3.3 is authorized.

## Prior runs retained

01:10, 03:06, 05:06, 06:09, 07:08, 12:08, 13:08, 14:11, 15:07, 16:06 and 17:10 CST scans are retained by the durable ledger/history. Formal BUY remained NONE. `603658 安图生物` remained the only execution-eligible durable deep-research candidate; its 2026H1 attributable profit -12.94% YoY, operating cash flow -47.38% YoY and capacity-project reallocation remain controlling blockers.

---

## 2026-08-26 19:07 CST — opportunity + holdings-risk refresh — SUPERSEDED HOLDINGS SECTION

### Fresh-data / production guardrails

- `603658 安图生物`: public sources observed ~33.48–33.49 during 2026-08-26, but the company IR quote was internally inconsistent and a second independently accepted exact 15:00 close was not recovered. Therefore the execution-grade accepted close remained 34.17 on 2026-08-25 and Formal BUY/ADD remained blocked.
- No new execution-eligible A1/A2 candidate was established. `603658` remained WAIT / Formal BUY = NO.

### Candidate delta

- `603658 安图生物`: **RESEEN / PRICE_OBSERVED_ONLY**; last_seen -> 19:07 CST; seen_count -> 12. H1 earnings/cash-flow weakness, incomplete normalized Bear/Base/Bull valuation and the unresolved capacity-expansion-to-R&D capital-allocation signal remained controlling blockers. No tier, valuation or entry-band upgrade.

### Holdings-integrity correction

- The original 19:07 holdings subsection incorrectly carried a historical/stale holding universe containing `600879 航天电子` and other names that were **not present in the then-current `CURRENT_HOLDINGS.md`**. That subsection and the resulting `600879 REDUCE` notification are **SUPERSEDED / NON-CONTROLLING** and must not be treated as a user holding instruction.
- `CURRENT_HOLDINGS.md` is the sole holdings-universe truth. As of its user-confirmed 2026-08-25 snapshot, the only confirmed holdings are `603369 今世缘`, `001316 润贝航科`, `600276 恒瑞医药`, and `600406 国电南瑞`.
- Root cause is classified as **HOLDINGS_UNIVERSE_CONTEXT_DRIFT**, not a V3.1 valuation-model defect. Mitigation: each risk refresh must reconstruct the holding universe exclusively from the latest `CURRENT_HOLDINGS.md` and must never union names from prior logs/handoffs.

---

## 2026-08-26 20:09 CST — authoritative opportunity + CURRENT_HOLDINGS risk refresh

### Rules / source-of-truth refresh

- Re-read current `main` `AGENTS.md`, `CURRENT_MARKET_RESEARCH.md`, `RESEARCH_QUEUE.md`, `MODEL_EVOLUTION_LOG.md`, `V31_DURABLE_HANDOFF.md`, `V31_CANDIDATE_LEDGER.md`, `CURRENT_HOLDINGS.md` and this dated log.
- Holdings universe was rebuilt exclusively from `CURRENT_HOLDINGS.md`: `603369`, `001316`, `600276`, `600406`. Historical-log holdings were excluded.
- Fresh-data invariant remains binding; no stale/unverified exact price can create Formal BUY/ADD or price-only REDUCE/EXIT.

### Opportunity scan / candidate delta

- `603658 安图生物`: **RESEEN / PRICE_OBSERVED_ONLY**; `last_seen` -> 20:09 CST; `seen_count` -> 13. After-close reporting confirms a 2.22% decline on 2026-08-26, consistent with earlier same-day low-33 observations, but direct exact-close sources remain incomplete/inconsistent and the company IR quote remains erroneous. Accepted exact close therefore remains 34.17 CNY on 2026-08-25.
- Tier remains **WAIT**; Formal BUY **NO**. Blockers unchanged: H1 attributable profit -12.94%, operating cash flow -47.38%, unresolved capacity-expansion-project termination / ~8.12亿元 R&D reallocation interpretation, incomplete moat/predictability audit, normalized earnings and Bear/Base/Bull reverse valuation.
- No new execution-eligible A1/A2 candidate; no valuation/buy-band upgrade; no INVALIDATED name.

### Current holdings risk scan

- `603369 今世缘`: **HOLD_REVIEW / NO ADD**. Accepted 2026-08-26 close **28.10 CNY**. H1 revenue/profit weakness and structural baijiu demand/channel pressure remain material, but operating cash flow improvement and no newly verified moat/thesis break mean no REDUCE/EXIT.
- `001316 润贝航科`: **HOLD**. Latest H1 evidence remains strong: revenue +21.97%, attributable profit +44.82%, deduct-profit +45.14%, operating cash flow +26.52%. The convertible-bond application withdrawal is noted without verified operating impairment. Exact 2026-08-26 close was not independently accepted, therefore no price-dependent action.
- `600276 恒瑞医药`: **HOLD_REVIEW**. Accepted 2026-08-26 close **46.74 CNY**. H1 deduct-profit/cash-flow quality remains under review; the 2026-08-25 drug marketing-application acceptance is pipeline-supportive. No durable innovation-pipeline/moat break and no REDUCE/EXIT trigger established.
- `600406 国电南瑞`: **HOLD**. Accepted 2026-08-26 close **23.42 CNY**. No new material event falsifies grid digitization/UHV demand or its grid-control/customer-certification moat. No REDUCE/EXIT trigger.
- **New REDUCE/EXIT:** NONE. **New holding thesis invalidation:** NONE.

### Delta / notification decision

- **Ledger delta:** `603658` RESEEN / PRICE_OBSERVED_ONLY.
- **NEW / UPGRADED candidate:** none.
- **Formal BUY / ADD:** NONE.
- **Current-holdings REDUCE / EXIT:** NONE.
- **Production/data integrity:** **HOLDINGS_UNIVERSE_CONTEXT_DRIFT identified and corrected.** The old 19:07 non-current holdings risk section is superseded; current holding decisions must use this 20:09 reconciliation plus `CURRENT_HOLDINGS.md`.
- **Notification trigger:** YES — production/data-integrity correction materially invalidates the prior 600879 holding REDUCE notification.